MMV ups funding under deal with Anacor to allow Phase I trial of malaria candidate
01 September 2011
Pial Ganguli
Please Login to read the full article.
01 September 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- 'Microbiological finding' sees a halt to GSK/Anacor's antibiotic trials
- Boron compound from Anacor prepares for Phase III psoriasis trials
- Orchid's PDE-4 inhibitor shows early promise in European study
- Rib-X Pharma files for IPO to finance antibiotics providing superior coverage
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
